Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

Abstract

High-calorie diet has been shown to impair learning ability and hippocampal synaptic plasticity in rodents. This study examined effects of daily treatment with the glucagon-like peptide-1 mimetic, exendin-4, on cognitive function and hippocampal synaptic plasticity in a model of diet-induced obesity, which exhibits compromised cognitive performance. Mice fed a high-fat diet were treated with exendin-4 (25 nmol kg−1 bodyweight; twice daily) or saline vehicle (0.9% (w/v) NaCl) over 21 days. In addition to improving metabolic control, exendin-4-treated mice exhibited a marked increase in recognition index highlighting improved learning and memory. High-fat diet resulted in the elimination of in vivo electrophysiological long-term potentiation, which was rescued following exendin-4 treatment. This study shows that exendin-4 therapy improves cognitive function and ameliorates impaired hippocampal synaptic plasticity in dietary-induced obesity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Lovshin JA, Drucker DJ . Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009; 5: 262–269.

    Article  CAS  Google Scholar 

  2. Hamilton A, Hölscher C . Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport 2009; 20: 1161–1166.

    Article  CAS  Google Scholar 

  3. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003; 9: 1173–1179.

    Article  CAS  Google Scholar 

  4. Abbas T, Faivre E, Hölscher C . Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res 2009; 205: 265–271.

    Article  CAS  Google Scholar 

  5. Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM et al. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J Neurosci Res 2003; 72: 603–612.

    Article  CAS  Google Scholar 

  6. Gault VA, Hölscher C . GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol 2008; 587: 112–117.

    Article  CAS  Google Scholar 

  7. Kastin AJ, Akerstrom V, Pan W . Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 2002; 18: 7–14.

    Article  CAS  Google Scholar 

  8. Stranahan AM, Normal ED, Lee K, Cutler RG, Telljohann RS, Egan JM et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008; 18: 1085–1088.

    Article  Google Scholar 

  9. Flatt PR, Bailey CJ . Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 1981; 20: 573–577.

    Article  CAS  Google Scholar 

  10. Trudeau F, Gagnon S, Massicotte G . Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004; 490: 177–186.

    Article  CAS  Google Scholar 

  11. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y et al. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight and energy expenditure. J Clin Invest 2007; 117: 143–152.

    Article  CAS  Google Scholar 

  12. McGovern SF, McClean P, Gault VA, Holscher C . Novel GLP-1 Analogues Improve Memory Formation—A Link Between Diabetes and Alzheimer's Disease. Neuroscience Annual Meeting; 2009; Society for Neuroscience: Chicago, IL, Abstract 529.7.

  13. Zachrisson O, Isacson R, Nielsen E, Bertilsson G, Dannaeus K, Wikstrom LB . Exendin-4 Stimulates Hippocampal Neurogenesis and Exerts Affective and Cognition Associated Effects in Behavioral Models. Neuroscience Annual Meeting; 2009; Society for Neuroscience: Chicago, IL, Abstract 549.4.

Download references

Acknowledgements

These studies were supported by University of Ulster Strategic Research Funding and the SAAD Trading and Contracting Company.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V A Gault.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gault, V., Porter, W., Flatt, P. et al. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Int J Obes 34, 1341–1344 (2010). https://doi.org/10.1038/ijo.2010.59

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2010.59

Keywords

This article is cited by

Search

Quick links